The specialist integrated CDMO

Browser not supported

Oops! Your browser version is not supported by our website.
Please use these following browsers to view this page:

Knowledge Center

Patent

Dry powder inhaler pharmaceutical composition of coated crystalline dry powder for inhalation

Jan 11, 2024 WO 2024009079 A1

Patent

Pharmaceutical composition containing sugar and lipid composite particles for inhalation and method for manufacturing same

Dec 28, 2023 WO 2023247952 A1

Webinar

Webinar - Nasal powder delivery: Process, formulation and analytical characterization

Nov 30, 2023 Webinar

Poster

Hot and Cold Formulation of Biologics for the Optimization of Drying Technologies

Oct 23, 2023 AAPS 2023

Webinar

Webinar - Accessing Continuous Tableting Through a CDMO

Oct 11, 2023 Webinar

Patent

Inhalable pharmaceutical composition containing spray dried cohesive composite active particles and carrier based formulation combination

Oct 05, 2023 WO 2023187393

Webinar

Webinar - High performance solutions for DPI delivery: new formulation and device platforms

Oct 04, 2023 Webinar

Article

Driving Dosage Form Developments

Sep 29, 2023 Pharmaceutical Technology

Article

Hazards of a N-Bromosuccinimide Solution in N,N-Dimethylformamide

Sep 25, 2023 American Chemical Society, 25 September 2023

Article

Amorphous Nasal Powder Advanced Performance: "In Vitro/Ex Vivo" Studies and Correlation with "In Vivo" Pharmacokinetics

Sep 18, 2023 Journal of Pharmaceutical Investigation, 18 September 2023

Article

In vitro dissolution/permeation tools for amorphous solid dispersions bioavailability forecasting II: Comparison and mechanistic insights

Sep 01, 2023 European Journal of Pharmaceutical Sciences (2023), 188, 106513

Article

In vitro dissolution/permeation tools for amorphous solid dispersions bioavailability forecasting I: Experimental design for PermeaLoop

Sep 01, 2023 European Journal of Pharmaceutical Sciences (2023), 188, 106512

Browser not supported

Knowledge Center

Scientific Article Type

Authors

Publish Date

Dry powder inhaler pharmaceutical composition of coated crystalline dry powder for inhalation

Pharmaceutical composition containing sugar and lipid composite particles for inhalation and method for manufacturing same

Webinar - Nasal powder delivery: Process, formulation and analytical characterization

Hot and Cold Formulation of Biologics for the Optimization of Drying Technologies

Webinar - Accessing Continuous Tableting Through a CDMO

Inhalable pharmaceutical composition containing spray dried cohesive composite active particles and carrier based formulation combination

Webinar - High performance solutions for DPI delivery: new formulation and device platforms

Driving Dosage Form Developments

Hazards of a N-Bromosuccinimide Solution in N,N-Dimethylformamide

Amorphous Nasal Powder Advanced Performance: "In Vitro/Ex Vivo" Studies and Correlation with "In Vivo" Pharmacokinetics

In vitro dissolution/permeation tools for amorphous solid dispersions bioavailability forecasting II: Comparison and mechanistic insights

In vitro dissolution/permeation tools for amorphous solid dispersions bioavailability forecasting I: Experimental design for PermeaLoop